Heparan Sulfate Proteoglycans Initiate Dengue Virus Infection of Hepatocytes
- 1 November 2000
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 32 (5) , 1069-1077
- https://doi.org/10.1053/jhep.2000.18713
Abstract
Dengue viruses (DEN) cause a broad spectrum of clinical manifestations including potentially life–threatening conditions such as hemorrhagic shock syndrome and less frequently acute hepatitis with liver failure and encephalopathy. In addition, dengue viruses provide a potential model to understand the initiation of hepatocyte infection by the structurally closely related hepatitis C virus (HCV), because this virus at present cannot be grown in cell culture. Although the initial steps of viral infection are a critical determinant of tissue tropism and therefore pathogenesis, little is known about the molecular basis of binding and endocytic trafficking of DEN or of any other flavivirus. Our studies revealed that binding of radiolabeled DEN to the human hepatoma cell line HuH–7 was strictly pH dependent and substantially inhibitable by the glycosaminoglycan heparin. Ligand–blot analysis, performed as a viral overlay assay, showed two heparan sulfate (HS) containing cell–surface binding proteins resolving at 33 and 37 kd. Based on the sensitivity of unprotected virus and the viral binding site on the cell surface to trypsin, viral internalization was quantified as an increase in trypsin protected virus over time. Virus trafficking to the site of degradation was inhibited by pH dissociation of the clathrin coat and dependent on IP3–mediated homotypic endosomal fusion. These findings confirm the hypothesis that binding and internalization of DEN by hepatocytes are mediated primarily by HS containing proteoglycans and suggest that flaviviruses traffic the major clathrin–dependent endocytic pathway during infection.Keywords
This publication has 58 references indexed in Scilit:
- Detection of dengue virus RNA by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection.The American Journal of Tropical Medicine and Hygiene, 1999
- Development of a Novel Mouse Model for Dengue Virus InfectionVirology, 1999
- Report of a fatal case of dengue infection with hepatitis: Demonstration of dengue antigens in hepatocytes and liver apoptosisHuman Pathology, 1999
- The L1 Major Capsid Protein of Human Papillomavirus Type 11 Recombinant Virus-like Particles Interacts with Heparin and Cell-surface Glycosaminoglycans on Human KeratinocytesJournal of Biological Chemistry, 1999
- Syndecans: multifunctional cell-surface co-receptorsBiochemical Journal, 1997
- Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfateNature Medicine, 1997
- Dengue Fever at the US-Mexico Border, 1995-1996Published by American Medical Association (AMA) ,1996
- Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparinCarbohydrate Research, 1995
- Liver Biochemical Tests and Dengue FeverThe American Journal of Tropical Medicine and Hygiene, 1992
- The dengue virusesClinical Microbiology Reviews, 1990